Historical return extremes for Ovid Therapeutics (OVID) from 2017 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +1,061% | $0.26 | $2.96 | $11,607.84 | ||
| Max drawdownMore info about Max drawdown | -98.30% | $15 | $0.26 | $17.00 | ||
| Return since IPOMore info about Return since IPO | -81.22% | $12.25 | $2.30 | $187.76 |
- Max profitMore info about Max profit+1,061%$11,607.84
- Max drawdownMore info about Max drawdown-98.30%$17.00
- Return since IPOMore info about Return since IPO-81.22%$187.76
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Ovid Therapeutics (OVID). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Ovid Therapeutics (OVID) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement